ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Blast Crisis

Include trials that are no longer recruiting patients.

3 studies were found.
1.RecruitingPhase II trial of decitabine in patients with chronic myelogenous leukemia blast phase who are refractory to imatinib mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia
2.RecruitingClofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia
3.RecruitingSafety and Efficacy of Hum195/rGel in Patients with Advanced Myeloid Malignancies
Conditions: Myelodysplastic Syndromes; Leukemia, Myelocytic, Acute; Anemia, Refractory, with Excess of Blasts; Myeloproliferative Disorders

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act